Human equilibrative nucleoside transporter 1 (hENT1) expression as a predictive biomarker for gemcitabine chemotherapy in biliary tract cancer

Gemcitabine is a principal chemotherapeutic agent for biliary tract cancer (BTC). Expression of human equilibrative nucleoside transporter 1 (hENT1) is regarded as a potential predictive biomarker for a gemcitabine response in some cancers. This study was conducted to investigate the association bet...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:PLoS One
Egile Nagusiak: Kim, Jaihwan, Kim, Haeryoung, Lee, Jong-chan, Kim, Jin Won, Paik, Woo Hyun, Lee, Sang Hyub, Hwang, Jin-Hyeok, Ryu, Ji Kon, Kim, Yong-Tae
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Public Library of Science 2018
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6296552/
https://ncbi.nlm.nih.gov/pubmed/30557411
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0209104
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak